Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

The healthcare for transgender veterans could be better with a more unified team approach.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Finasteride may affect PNMT, causing side effects.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Finasteride helps reduce priapism in sickle cell anemia patients.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.